UNSPSC 51241543: Sodium biphosphate/sodium chloride/sodium phosphate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP500. This VA Drug Class (OP500) classifies this compound as belonging to the group EYE WASHES/LUBRICANTS.

UNSPSC 51241543 Sodium biphosphate/sodium chloride/sodium phosphate is a Commodity code under which state and local governments procure generic and over-the-counter pharmaceutical products, including electrolyte replacement formulations and saline solutions used in clinical and institutional settings. The work involves manufacturers supplying products with specific National Drug Codes (NDCs), managing pricing through authorized pharmaceutical wholesalers, and maintaining compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA). Issuing bodies under this code include state cooperative purchasing alliances and their participating member jurisdictions spanning multiple states and local government facilities.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted RFP S1070000015802 on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a proposal due date of March 26, 2026. Vendors supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and must certify cGMP and DSCSA compliance, maintain relationships with at least two of the three wholesalers, and carry insurance including $5,000,000 commercial general liability. Products must be available in the marketplace by May 15, 2026, with awarded vendors notified for wholesaler provision and resulting agreements effective July 1, 2026. Evaluation weights price competitiveness at 75 percent, with additional scoring on fixed pricing (10 percent), administrative fee compliance (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent). The contract term is two years for new responders with optional extensions, while incumbent amendments align with existing expiration dates through June 30, 2028. No specific set-aside designations or budget values are disclosed in available documentation.